These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1534664

  • 1. Effects of fosinopril on cardiac function in patients with hypertension. Radionuclide assessment of left ventricular systolic and diastolic performance.
    Zusman RM, Christensen DM, Higgins J, Boucher CA.
    Am J Hypertens; 1992 Apr; 5(4 Pt 1):219-23. PubMed ID: 1534664
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitors: more different than alike? Focus on cardiac performance.
    Zusman RM.
    Am J Cardiol; 1993 Dec 30; 72(20):25H-36H. PubMed ID: 8285179
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
    Zusman RM, Christensen DM, Higgins J, Boucher CA.
    J Cardiovasc Pharmacol; 1992 Aug 30; 20(2):216-22. PubMed ID: 1381012
    [Abstract] [Full Text] [Related]

  • 4. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
    Oren S, Messerli FH, Grossman E, Garavaglia GE, Frohlich ED.
    J Am Coll Cardiol; 1991 Apr 30; 17(5):1183-7. PubMed ID: 1826120
    [Abstract] [Full Text] [Related]

  • 5. Comparison of fosinopril and hydrochlorothiazide in patients with mild to moderate hypertension.
    Forslund T, Franzén P, Backman R.
    J Intern Med; 1991 Dec 30; 230(6):511-7. PubMed ID: 1836220
    [Abstract] [Full Text] [Related]

  • 6. The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.
    Waldemar G, Ibsen H, Strandgaard S, Andersen AR, Rasmussen S, Paulson OB.
    Am J Hypertens; 1990 Jun 30; 3(6 Pt 1):464-70. PubMed ID: 2142429
    [Abstract] [Full Text] [Related]

  • 7. Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension.
    Zusman RM, Christensen DM, Federman EB, Ruddy TD, Miller DD, Boucher CA.
    Am J Cardiol; 1989 Sep 19; 64(11):51F-61F. PubMed ID: 2782271
    [Abstract] [Full Text] [Related]

  • 8. An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril.
    Leonetti G, Trimarco B, Collatina S, Tosetti A.
    Am J Hypertens; 1997 Oct 19; 10(10 Pt 2):230S-235S. PubMed ID: 9366278
    [Abstract] [Full Text] [Related]

  • 9. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR, Drabaek H, Gleerup G, Mehlsen J, Petersen LJ, Winther K.
    Angiology; 1996 Mar 19; 47(3):233-40. PubMed ID: 8638865
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension.
    Lombardo M, Alli C, Broccolino M, Ferrari S, Montemurro L, Zaini G, Zanni D.
    Am Heart J; 1997 Sep 19; 134(3):557-64. PubMed ID: 9327716
    [Abstract] [Full Text] [Related]

  • 11. Left ventricular diastolic function during adrenergic stress in essential hypertension: acute and chronic effects of ACE inhibition.
    Covi G, Sheiban I, Gelmini G, Arcaro G, Tonni S, Bolner A, Piemonte G, Lechi A.
    Cardiovasc Drugs Ther; 1996 Jul 19; 10(3):321-9. PubMed ID: 8877075
    [Abstract] [Full Text] [Related]

  • 12. The effect of cilazapril on systolic and diastolic cardiac function in hypertensive patients.
    Schneeweiss A, Green T, Krakuer J, Goldhamer E, Szucs T, Marmor A.
    J Hum Hypertens; 1989 Aug 19; 3(4):251-4. PubMed ID: 2529375
    [Abstract] [Full Text] [Related]

  • 13. Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension.
    Sullivan PA, Dineen M, Cervenka J, O'Connor DT.
    Am J Hypertens; 1988 Jul 19; 1(3 Pt 3):280S-283S. PubMed ID: 2970855
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular hypertrophy and performance: therapeutic options among the angiotensin-converting enzyme inhibitors.
    Zusman RM.
    J Cardiovasc Pharmacol; 1992 Jul 19; 20 Suppl 10():S21-8. PubMed ID: 1283427
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
    Massien C, Azizi M, Guyene TT, Vesterqvist O, Mangold B, Ménard J.
    Clin Pharmacol Ther; 1999 Apr 19; 65(4):448-59. PubMed ID: 10223783
    [Abstract] [Full Text] [Related]

  • 16. Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension.
    Sullivan PA, Cervenka J, O'Connor DT, Dineen M.
    Cardiovasc Drugs Ther; 1989 Mar 19; 3(1):57-62. PubMed ID: 2535052
    [Abstract] [Full Text] [Related]

  • 17. Fosinopril (Staril)--another ACE inhibitor.
    Drug Ther Bull; 1991 Jun 10; 29(12):48. PubMed ID: 1834450
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension.
    Kamp O, Sieswerda GT, Visser CA.
    Am J Cardiol; 2003 Aug 01; 92(3):344-8. PubMed ID: 12888152
    [Abstract] [Full Text] [Related]

  • 19. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.
    DeForrest JM, Waldron TL, Harvey C, Scalese B, Mitch S, Powell JR, Petrillo W, Cushman DW.
    J Cardiovasc Pharmacol; 1990 Jul 01; 16(1):139-46. PubMed ID: 1696656
    [Abstract] [Full Text] [Related]

  • 20. Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS).
    Vetter W.
    Am J Hypertens; 1997 Oct 01; 10(10 Pt 2):255S-261S. PubMed ID: 9366282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.